Glucose Control in Critically Ill Patients — free guideline decision tool
Glycemic targets and insulin-management direction for critically ill patients, avoiding both hyperglycemia and hypoglycemia.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Current glucose | 200 |
|---|---|
| Unit | mg/dL |
| Population | Most critically ill patients (target 140–180 [unverified]) |
→Glucose200 mg/dL
- Glucose：200 mg/dL (11.1 mmol/L)
- Target range：Standard 140–180 mg/dL (7.8–10.0 mmol/L) [unverified]
- Status / management：Above target — ≥ 180 mg/dL (10 mmol/L): start or intensify IV insulin (SSC 2026 Rec. 92); investigate DKA/HHS, infection, steroids/parenteral nutrition and other triggers
| Current glucose | 200 |
|---|---|
| Unit | mmol/L |
| Population | Selected populations — postop/cardiac/neuro |
→Glucose3600 mg/dL
- Glucose：3600 mg/dL (200 mmol/L)
- Target range：pending update
- Status / management：Above target — ≥ 180 mg/dL (10 mmol/L): start or intensify IV insulin (SSC 2026 Rec. 92); investigate DKA/HHS, infection, steroids/parenteral nutrition and other triggers
Common questions
What is Glucose Control in Critically Ill Patients?
Glycemic targets and insulin-management direction for critically ill patients, avoiding both hyperglycemia and hypoglycemia.
How is Glucose Control in Critically Ill Patients calculated? What is the core formula?
Target generally 140–180 mg/dL (7.8–10.0 mmol/L) [unverified] for most critically ill; start or intensify IV insulin at ≥ 180 mg/dL (10 mmol/L) (SSC 2026 Rec. 92); avoid tight control (80–110) due to hypoglycemia harm; monitor frequently.
When is Glucose Control in Critically Ill Patients used?
Use in the ICU to select a blood-glucose target band and decide when to start IV insulin infusion, with attention to avoiding hypoglycemia.
What are the key clinical points for Glucose Control in Critically Ill Patients?
A moderate target (140–180 mg/dL [unverified]) balances the harms of hyperglycemia against the hypoglycemia risk of tight control (original synthesis · not guideline verbatim). Tight glucose control (NICE-SUGAR) increased severe hypoglycemia and mortality, so it is no longer recommended. Frequent point-of-care monitoring and a validated infusion protocol reduce both hyper- and hypoglycemic excursions.
What are the limits and cautions when using Glucose Control in Critically Ill Patients?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
Does Glucose Control in Critically Ill Patients upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is Glucose Control in Critically Ill Patients calculated in practice? Can you show a worked example?
Inputs: Current glucose 200, Unit mg/dL, Population Most critically ill patients (target 140–180 [unverified]) → Result: Glucose 200 mg/dL（Glucose: 200 mg/dL (11.1 mmol/L), Target range: Standard 140–180 mg/dL (7.8–10.0 mmol/L) [unverified], Status / management: Above target — ≥ 180 mg/dL (10 mmol/L): start or intensify IV insulin (SSC 2026 Rec. 92); investigate DKA/HHS, infection, steroids/parenteral nutrition and other triggers） Inputs: Current glucose 200, Unit mmol/L, Population Selected populations — postop/cardiac/neuro → Result: Glucose 3600 mg/dL（Glucose: 3600 mg/dL (200 mmol/L), Target range: pending update, Status / management: Above target — ≥ 180 mg/dL (10 mmol/L): start or intensify IV insulin (SSC 2026 Rec. 92); investigate DKA/HHS, infection, steroids/parenteral nutrition and other triggers）
Run Glucose Control in Critically Ill Patients now
Glycemic targets and insulin-management direction for critically ill patients, avoiding both hyperglycemia and hypoglycemia.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.